Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A12 | Q96S37 | 6/20 | 1.00 |
| ▸ | SLC2A9 | Q9NRM0 | 2/20 | 1.00 |
| ▸ | XDH | P47989 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 0.82 |
| ▸ | POLB | P06746 | 2/20 | 0.82 |
| ▸ | MAPT | P10636 | 2/20 | 0.82 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.82 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.82 |
| ▸ | MITF | O75030 | 1/20 | 0.82 |
| ▸ | ALPL | P05186 | 1/20 | 0.82 |
| ▸ | ALPI | P09923 | 1/20 | 0.82 |
| ▸ | GAA | P10253 | 1/20 | 0.82 |
| ▸ | ALPG | P10696 | 1/20 | 0.82 |
| ▸ | PKM | P14618 | 1/20 | 0.82 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.78 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.78 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.78 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.75 |
| ▸ | ESR1 | P03372 | 3/20 | 0.72 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isobavachin SCHEMBL27013463 | 1.00 | SLC22A12 (1.00) | SLC22A12SLC2A9XDHMEN1POLB | |
| Isobavachin SCHEMBL31620056 | 1.00 | SLC22A12 (1.00) | SLC22A12SLC2A9XDHMEN1POLB | |
| SCHEMBL14523865 | 0.91 | SLC22A12 (0.83) | SLC22A12SLC2A9XDHMEN1POLB | |
| Glabrol SCHEMBL15602627 | 0.88 | PTPN1 (1.00) | SLC22A12SLC2A9XDHMEN1POLB | |
| Glabrol SCHEMBL745275 | 0.88 | PTPN1 (1.00) | SLC22A12SLC2A9XDHMEN1POLB | |
| SCHEMBL5518672 | 0.87 | SLC22A12 (0.77) | SLC22A12SLC2A9XDHMEN1POLB | |
| SCHEMBL28635979 | 0.86 | SLC22A12 (0.76) | SLC22A12SLC2A9XDHMEN1POLB | |
| SCHEMBL29425241 | 0.86 | PTPN1 (0.84) | SLC22A12SLC2A9XDHMEN1POLB | |
| SCHEMBL3064706 | 0.86 | PTPN1 (0.84) | SLC22A12SLC2A9XDHMEN1POLB | |
| Sophoraflavanone B SCHEMBL29396586 | 0.84 | ESR1 (1.00) | SLC22A12SLC2A9XDHMEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115728430-A | Fingerprint construction method and identification method of fructus psoraleae and fructus psoraleae salt traditional Chinese medicine formula granules | 广东一方制药有限公司 | 2023-03-03 | — | — | CN | claimed |
| CN-115684376-A | Method for simultaneously determining contents of various fructus psoraleae substances in lung tonifying and blood circulation promoting capsule by adopting one-time multi-evaluation method | 广东雷允上药业有限公司 | 2023-02-03 | — | — | CN | claimed |
| CN-115616107-A | Method for constructing characteristic map of bone-recovering preparation and characteristic map thereof | 贵州维康子帆药业股份有限公司 | 2023-01-17 | — | — | CN | claimed |
| CN-109283274-B | Multi-component content determination method of Hedan tablets | 南昌济顺制药有限公司 | 2022-08-30 | — | — | CN | claimed |
| CN-114796188-A | Plant-derived flavone antibacterial compound and application thereof | 朱奎 | 2022-07-29 | — | — | CN | claimed |
| CN-101273983-B | Use of neurocyte differentiated from stem cell induced by isobavachin | ZHEJIANG UNIVERSITY (CN) | 2011-11-30 | — | — | CN | claimed |
| CN-101273983-A | Use of neurocyte differentiated from stem cell induced by isobavachin | UNIV ZHEJIANG (CN) | 2008-10-01 | — | — | CN | claimed |
| US-20070092551-A1 | Therapeutic agent | TAKARA BIO INC. (JP) | 2007-04-26 | — | — | US | claimed |
| CN-1816328-A | Therapeutic agent | TAKARA BIO INC (JP) | 2006-08-09 | — | — | CN | claimed |
| EP-1623704-A1 | THERAPEUTIC AGENT | TAKARA BIO INC. (JP) | 2006-02-08 | — | — | EP | claimed |
| WO-2004022080-A2 | BUGUZHI AGENT AND COMPOSITION AND METHODS OF PREPARING AND ADMINISTERING THE SAME | THE UNIVERSITY OF HONG KONG (CN) | 2004-03-18 | — | — | WO | claimed |
| WO-2001001996-A9 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS | UNIV WESTERN AUSTRALIA (AU) | 2002-09-12 | — | — | WO | claimed |
| WO-2001001996-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS | UNIVERSITY OF WESTERN AUSTRALIA (AU) | 2001-01-11 | — | — | WO | claimed |
| JP-6133733-A | — | — | None | — | — | JP | disclosed |
| CN-120142639-A | Method for uric acid detection | 南方医科大学 | 2025-06-13 | — | — | CN | disclosed |
| WO-2024189607-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT | DIDENKO KIRILL (MX) | 2024-09-19 | — | — | WO | disclosed |
| WO-2001001996-A9 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS | UNIV WESTERN AUSTRALIA (AU) | 2002-09-12 | — | — | WO | disclosed |
| WO-2001001996-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS | UNIVERSITY OF WESTERN AUSTRALIA (AU) | 2001-01-11 | — | — | WO | disclosed |
| CN-1170588-A | Pure natural plant human life energy nutritive substrate | HAO LAIQIN (CN) | 1998-01-21 | — | — | CN | disclosed |
| JP-H06133733-A | NEW FUNCTIONAL FOOD | MARUHO KK | 1994-05-17 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070092551-A1 | Therapeutic agent | FABP4, GPR119, IAPP | SLC22A12 241/4885SLC2A9 44/4885XDH 3177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.